Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacep.2021.03.015 | DOI Listing |
J Arrhythm
December 2024
Department of Pediatric Cardiology Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences Istanbul Turkey.
Introduction: Although amiodarone is traditionally used in the treatment of postoperative junctional ectopic tachycardia (JET), the search for new treatments is ongoing. We present our experience with ivabradine at two medical centers.
Materials And Methods: Between January 2022 and January 2023, patients who developed JET after pediatric cardiac surgery were prospectively followed up and documented.
Br J Anaesth
October 2024
Division of Anaesthesiology, Department of Anaesthesiology, Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland; Department of Anaesthesiology, Pharmacology, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address:
Background: Perioperative myocardial injury after noncardiac surgery is associated with postoperative mortality. Heart rate (HR) is an independent risk factor for perioperative myocardial injury. In this pilot trial we tested the feasibility of a randomised, placebo-controlled trial of personalised HR-targeted perioperative ivabradine.
View Article and Find Full Text PDFJ Innov Card Rhythm Manag
July 2023
Division of Pediatric Cardiology, Department of Pediatrics, Norton Children's Hospital, University of Louisville School of Medicine, Louisville, KY, USA.
Pediatric postoperative junctional ectopic tachycardia (JET), although usually self-limited, may lead to significant morbidity and mortality. Anti-arrhythmic medications are often necessary to restore atrioventricular synchrony when non-pharmacological measures fail. Multiple drugs have been described for the management of postoperative JET, with enteral ivabradine being the latest addition.
View Article and Find Full Text PDFAnn Card Anaesth
November 2023
Department of Cardiothoracic Surgery, G B Pant Institute of Postgraduate Medical Education and Research, J L Nehru Marg, New Delhi, India.
Background: Ivabradine is a specific heart rate (HR)-lowering agent which blocks the cardiac pacemaker I channels. It reduces the HR without causing a negative inotropic or lusitropic effect, thus preserving ventricular contractility. The authors hypothesized that its usefulness in lowering HR can be utilized in patients undergoing off-pump coronary artery bypass (OPCAB) surgery.
View Article and Find Full Text PDFBraz J Cardiovasc Surg
December 2022
Department of Cardiovascular Surgery, Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul, Turkey.
Introduction: Classic coronary artery bypass grafting (CABG) surgery involves diastolic cardiac arrest under cardiopulmonary bypass, while off-pump CABG (OPCABG) has become widespread in recent years.
Methods: 174 patients who underwent OPCABG were included in the study. Patients were divided into two groups.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!